Abstract

Advances in genomic science and technology have had a significant impact on the delivery of reproductive healthcare. At the same time, these technologies generate a series of unprecedented challenges for patients and healthcare providers alike. Decision-making is at the core of the translational process bringing the use of genomics into reproductive and prenatal medicine. The full potential of these tests can only be realized if patients are able to make informed, values-based decisions about their use. This chapter examines the multi-faceted aspects that affect the translation of genomics in the reproductive context, with an emphasis on decision-making as a key component of this process, and argues that we must continue to invest in the research and development of women’s decision-making around the use of these genomic technologies.